These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 555600)

  • 1. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ; Tashkin DP; Ho D; Child JS
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
    Tinkelman DG; Brandon ML; Grieco M; Hudson L; Rosenthal RR; Spector SL; Tashkin D; Votteri B
    Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma.
    Littner MR; Tashkin DP; Calvarese B; Bautista M
    Ann Allergy; 1982 Jan; 48(1):14-20. PubMed ID: 7055342
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of albuterol and metaproterenol syrup in the treatment of childhood asthma.
    Wolfe JD; Shapiro GG; Ratner PH
    Pediatrics; 1991 Aug; 88(2):312-9. PubMed ID: 1861931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bronchodilator effect of fenoterol (Berotec).
    Powles AC
    N Z Med J; 1975 Mar; 81(535):249-51. PubMed ID: 1055321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirbuterol vs. hydroxyzine vs. theophylline vs. placebo in the treatment of bronchial asthma.
    Brandon ML
    Ann Allergy; 1980 Jul; 45(1):8-12. PubMed ID: 7406244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of pirbuterol acetate, metaproterenol, and placebo aerosols on pulmonary function and incidence of cardiac ectopy.
    Chodosh S; Crooks LA; Tuck J
    J Asthma; 1989; 26(5):309-15. PubMed ID: 2484663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
    Richards DM; Brogden RN
    Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirbuterol in the treatment of bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):18-25. PubMed ID: 367975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler.
    Völkl KP; Kroll VM; Wiesemann HG; Schneider B
    Arzneimittelforschung; 1991 May; 41(5):533-6. PubMed ID: 1680327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices.
    Tinkelman DG; Lutz C
    Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction.
    Poppius H; Lehti H; Stenius-Aarniala B
    Eur J Clin Pharmacol; 1979 Jul; 15(6):389-93. PubMed ID: 387417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics.
    Willey RF; Grant IW; Pocock SJ
    Br J Clin Pharmacol; 1976 Aug; 3(4):595-600. PubMed ID: 22216500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The oral application of berotec in the therapy of obstructive airway diseases].
    Veres R
    Fortschr Med; 1978 Mar; 96(10):553-7. PubMed ID: 631690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
    Mazza JA; Tashkin DP; Reed CE
    Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaproterenol sulfate for asthmatic children with therapeutic serum theophylline concentrations.
    Kelly HW; Menendez R; Murphy S; Tuttle W
    Clin Pharm; 1982; 1(1):49-54. PubMed ID: 6764162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.